In the current value-driven healthcare system, outcomes research plays an increasingly important role in health care decision making. At Excelra, we bridge the gap between the clinical and commercial teams, to evaluate the totality of real-world evidence to assess the benefits of the intervention, and develop evidence tailored to the product value strategy. Our clients get customized solutions for their drugs with the analysis of healthcare database cohort studies, assessment of published literature through our flagship database services, economic analyses, as well as value communication material for publication and health technology assessments.

Data to Evidence


Benefit from our expertise across data solutions, indexing, abstraction and data analytics

  • 15 of 20 Top pharma companies
  • 600+ Strong scientific talent pool
  • > 90 Disease areas covered

Outcomes delivered:

We help clients harmonize the value message for target interventions in the drug development cycle

  • Support clients develop evidence tailored to the product value strategy
  • Solving approval and reimbursement challenges with data-driven insights
  • Scalable and sustainable healthcare solutions powered by technology

Service offering:

  • Value dossiers
  • Literature reviews and gap analyses
  • Publications
  • Economic evaluations
  • Communication tools for value discussions

To explore our services, write to us at

Scroll To Top